Suppr超能文献

鼻咽癌颈淋巴结转移包膜外扩散的预后

Prognosis of Extracapsular Spread of Cervical Lymph Node Metastases in Nasopharyngeal Carcinoma.

作者信息

Yin Xue, Lv Lu, Pan Xin-Bin

机构信息

Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.

出版信息

Front Oncol. 2020 Sep 25;10:523956. doi: 10.3389/fonc.2020.523956. eCollection 2020.

Abstract

PURPOSE

This study aims to identify the prognosis of the extracapsular spread (ECS) of cervical lymph node metastases in nasopharyngeal carcinoma (NPC).

MATERIALS AND METHODS

Patients with NPC were extracted from the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2016. Pathologically confirmed World Health Patients with World Health Organization types I, II, and III NPC with complete ECS data of cervical lymph node metastases were investigated. The included patients were divided into non-ECS and ECS groups. The 10-year overall survival (OS) and cancer-specific survival (CSS) were compared between the two groups using the Kaplan-Meier method and propensity score matching analyses.

RESULTS

A total of 625 patients were included. The ECS group included 99 (15.84%) patients. The non-ECS group included 526 (84.16%) patients. The 10-year OS (50.2 vs. 35.8%; < 0.001) and CSS (64.8 vs. 45.7%; < 0.001) were better in the non-ECS group than in the ECS group in the unmatched cohort. Propensity score matching analyses revealed favorable 10-year OS (52.7 vs. 35.8%; = 0.008) and CSS (61.2 vs. 45.7%; = 0.008) in the non-ECS group with respect to the ECS group. Age, sex, race, AJCC stage, and ECS (hazard ratio (HR) = 1.71, 95% confidence interval (CI), 1.14-2.57, = 0.010) were independent prognostic factors for OS. Age, sex, AJCC stage, and ECS (HR = 1.91; 95% CI, 1.21-3.01; = 0.005) were independent prognostic factors for CSS.

CONCLUSION

This study indicated that ECS is a prognostic risk factor for NPC. Further studies should be performed to verify the results due to the limitations of the SEER database.

摘要

目的

本研究旨在确定鼻咽癌(NPC)颈部淋巴结转移的包膜外扩散(ECS)的预后情况。

材料与方法

从2004年至2016年的监测、流行病学和最终结果(SEER)数据库中提取NPC患者。对经病理证实的世界卫生组织I、II和III型NPC且有颈部淋巴结转移完整ECS数据的患者进行研究。将纳入的患者分为非ECS组和ECS组。采用Kaplan-Meier法和倾向评分匹配分析比较两组的10年总生存率(OS)和癌症特异性生存率(CSS)。

结果

共纳入625例患者。ECS组包括99例(15.84%)患者。非ECS组包括526例(84.16%)患者。在未匹配队列中,非ECS组的10年OS(50.2%对35.8%;<0.001)和CSS(64.8%对45.7%;<0.001)优于ECS组。倾向评分匹配分析显示,非ECS组相对于ECS组的10年OS(52.7%对35.8%;=0.008)和CSS(61.2%对45.7%;=0.008)较好。年龄、性别、种族、美国癌症联合委员会(AJCC)分期和ECS(风险比(HR)=1.71,95%置信区间(CI),1.14 - 2.57,=0.010)是OS的独立预后因素。年龄、性别 、AJCC分期和ECS(HR = 1.91;95% CI,1.21 - 3.01;=0.005)是CSS的独立预后因素。

结论

本研究表明ECS是NPC的预后危险因素。由于SEER数据库的局限性,应进行进一步研究以验证结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a629/7546023/bb1f1e02dab2/fonc-10-523956-g001.jpg

相似文献

2
Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma.化疗对I期鼻咽癌患者生存的疗效
Front Oncol. 2021 Oct 14;11:735817. doi: 10.3389/fonc.2021.735817. eCollection 2021.
3
Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma.鼻咽癌 N 分期的咽后淋巴结转移。
PLoS One. 2021 Jun 17;16(6):e0253424. doi: 10.1371/journal.pone.0253424. eCollection 2021.
6
The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma.化疗对II期鼻咽癌患者生存率的疗效。
Oral Oncol. 2020 Feb;101:104520. doi: 10.1016/j.oraloncology.2019.104520. Epub 2019 Dec 13.

本文引用的文献

2
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验